大行评级丨RBC Capital:降默沙东评级至“与大市同步”,癌症疫苗利多不敌估值压力

格隆汇
Aug 21
RBC Capital Markets将默沙东的目标价从142美元上调至150美元,评级从“优于大市”下调至“与大市同步”。分析师Trung Huynh认为,默沙东目前股价已相当程度反映其风险与回报,估值倍数中已包含大量乐观预期,因此从目前水平来看,上涨空间有限。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10